SHPH Shuttle Pharmaceuticals Holdings, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
14:27
Jan 16
Jan 16
SHPH short squeeze on low float and borrow
The author argues SHPH is a prime short squeeze candidate citing a low float of 1.55 million shares, only 15,000 shares available to borrow, and borrow costs above 88%. He notes the stock is already up 20%+ premarket and expects it to take off. The squeeze mechanism is driven by limited supply of borrowable shares against short positions.
MED
21:41
Jan 13
Jan 13
Utah AI drug rule boosts SHPH's molecule.ai
The author claims Utah's approval of AI prescription drugs aligns with Shuttle Pharmaceuticals' recently acquired molecule.ai, positioning the technology as an essential tool for modern drug discovery. The causal mechanism is that the regulatory change makes AI-driven drug discovery state-approved, driving demand for molecule.ai's platform. The catalyst is the Utah regulatory approval, with no explicit time horizon given. No specific risk is stated by the author.
MED
About SHPH Investor Commentary
Across the available history and selected sources, Buzzberg tracks SHPH (Shuttle Pharmaceuticals Holdings, Inc.) across 1 sources: 2 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/No_Courage_7210, u/quota_flash.